New crown therapeutic drug centronavir tablets/ritonavir tablets combination package first offer announcement
Read Time:53 Second
According to the “Office of the National Health Insurance Administration on the issuance of notice” (Medical Insurance Office issued [2023] No. 2) requirements, the Hainan Centrum Pharmaceutical Co., Ltd. cenotecanide tablets / ritonavir tablets combination package first offer information is now publicized (see Annex). Public notice period from January 31 to February 6, 2023, if there are objections, please submit the following ways to the Bureau of the real name during the public notice period, and provide legal and effective evidence materials (the name of the unit to be sealed). Failure to provide the corresponding evidence materials, in principle, will not be accepted.
- E-mail: [email protected]
- Letter: Beijing Municipal Medical Security Bureau Office, 11F, No.1 Xisanhuan South Road, Fengtai District, Beijing, 100071, and please indicate the word “public opinion” on the envelope.
- Fax: 010-89152514
Annex: 1. First offer of cenotecanavir tablets/ritonavir tablets combination package
- Clinical professional opinion of cenotecanavir tablets/ritonavir tablets combination package
- Centronavir tablet/ritonavir tablet combination package industry association recommendation
Beijing Municipal Medical Security Bureau
January 30, 2023
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
0
0
Average Rating